description

According to Reuters Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker. Takeda in a press release said it received unconditional clearance from the United States Federal Trade Commission. The Tokyo-listed firm is still awaiting approval from regulators in China, the European Union and elsewhere,.

general info

  • Uploaded    07/11/2018
  • Business & Finance
  • Instagram Says It Will Block Anti-Vaccine Hashtags
  • Netflix Tests $4 Mobile-Only Subscription Plan In India
  • GameStop Wants To Become "Cultural Experience," Not Just A Store
  • Wall Street tumbles, yields fuel economic fears
  • Doctolib 'unicorn' bets on video doctors
  • Take some profit, get defensive, says Ed Confrancesco
  • Elon Musk Wants Employees To Deliver On Upcoming Tesla Deliveries
  • Shaquille O'Neal Joins Papa John's Board And Signs Endorsement Deal
  • Top 5 Quotes From JP Morgan Chase CEO Jamie Dimon